ConductScience.org, home

Paper26344467

Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine.

Li W and 2 others. Vaccines (Basel), 2013. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine. Papers, record 26344467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26344467

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine.
PubMed
Journal
Vaccines (Basel)
PubMed
Year
2013
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.3
iCite
Revised in PubMed
2020-10-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li WWei
2Wang SShixia
3Lu SShan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
U01 AI078073NIAID NIH HHSUnited StatesU01AI078073PubMed

Source NIH RePORTER

Download CSV of grants

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116987975
Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.
J Virol2006https://conductscience.org/library/papers/16987975PubMed
222094541Evaluation of CD4+/CD8+ T-cell expression and IFN-γ, perforin secretion for B-T constructs of F1 and V antigens of Yersinia pestis.Int Immunopharmacol2012https://conductscience.org/library/papers/22094541PubMed
318538900
Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.
Vaccine2008https://conductscience.org/library/papers/18538900PubMed
421760928Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets.PLoS One2011https://conductscience.org/library/papers/21760928PubMed
518724414Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers.Vaccine2008https://conductscience.org/library/papers/18724414PubMed
615908389Human immune response to a plague vaccine comprising recombinant F1 and V antigens.Infect Immun2005https://conductscience.org/library/papers/15908389PubMed
721199697Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.Vaccine2011https://conductscience.org/library/papers/21199697PubMed
820188257Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.Vaccine2010https://conductscience.org/library/papers/20188257PubMed
921975270DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials.Lancet Infect Dis2011https://conductscience.org/library/papers/21975270PubMed
1010717537Current epidemiology of human plague in Madagascar.Microbes Infect2000https://conductscience.org/library/papers/10717537PubMed
1116325880Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.Virology2006https://conductscience.org/library/papers/16325880PubMed
1221085486Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.PLoS One2010https://conductscience.org/library/papers/21085486PubMed
1315011977Yersinia pestis: still a plague in the 21st century.Clin Lab Sci2004https://conductscience.org/library/papers/15011977PubMed
1419500964Heterologous prime-boost vaccination.Curr Opin Immunol2009https://conductscience.org/library/papers/19500964PubMed
1520170767Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity.Vaccine2010https://conductscience.org/library/papers/20170767PubMed
1615919951Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1.J Virol2005https://conductscience.org/library/papers/15919951PubMed
1715174978Yersinia pestis (plague) vaccines.Expert Opin Biol Ther2004https://conductscience.org/library/papers/15174978PubMed
189269050A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague.Vaccine1997https://conductscience.org/library/papers/9269050PubMed
1919943765Prospects for new plague vaccines.Expert Rev Vaccines2009https://conductscience.org/library/papers/19943765PubMed
2015308359A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague.Vaccine2004https://conductscience.org/library/papers/15308359PubMed

See all 32 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
40529698Biological threat preparedness through vaccine development and stockpiling: challenges and strategic implications.Front Public Health2025https://conductscience.org/library/papers/40529698PubMed
34142207Plague vaccines: new developments in an ongoing search.Appl Microbiol Biotechnol2021https://conductscience.org/library/papers/34142207PubMed
30898066Antibody repertoire analysis of mouse immunization protocols using microfluidics and molecular genomics.MAbs2019https://conductscience.org/library/papers/30898066PubMed
30328017Recombinant neuraminidase pseudotyped baculovirus: a dual vector for delivery of Angiotensin II peptides and DNA vaccine.AMB Express2018https://conductscience.org/library/papers/30328017PubMed
29456657
Intramuscular primary immunization by nucleic acid vaccine pcDNA/Gpd-IL-2 and enhanced immunization with mucosal adjuvant CpG-ODN and Gpd-IL-2 recombinant protein effectively induced strong mucosal immune responses and immune protective effects against Treponema pallidum skin infection.
Exp Ther Med2018https://conductscience.org/library/papers/29456657PubMed
28956354Heterologous prime-boost immunization with live SPY1 and DnaJ protein of Streptococcus pneumoniae induces strong Th1 and Th17 cellular immune responses in mice.J Microbiol2017https://conductscience.org/library/papers/28956354PubMed
27048742DNA immunization as a technology platform for monoclonal antibody induction.Emerg Microbes Infect2016https://conductscience.org/library/papers/27048742PubMed
25488991Identification of Aim2 as a sensor for DNA vaccines.J Immunol2015https://conductscience.org/library/papers/25488991PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26344467

GET https://conductscience.org/api/papers/v1/26344467/references?page=2